Clinical Trial Update: Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke (CLEAR-FDR) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and potential efficacy of combining rt-PA (alteplase) with eptifibatide for acute ischemic stroke. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Infarction
• Stroke

Drugs mentioned

• Activase (alteplase) (alteplase)
• Integrilin (eptifibatide) (eptifibatide)

Snippet

Sponsor: Arthur Pancioli | Conditions: Stroke, Brain Infarction | Phase 2 | Status: COMPLETED | Results posted: 2015-11-25